NCT05565599View on ClinicalTrials.gov

An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

NAActive, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

August 7, 2024

Study Completion Date

September 1, 2029

Conditions
Non-valvular Atrial Fibrillation
Interventions
DEVICE

Left Atrial Appendage Closure

Closure of the left atrial appendage with the Laminar Left Atrial Appendage Closure System.

Trial Locations (7)

10029

The Mount Sinai Hospital, New York

10032

Columbia U. Medical Center / NY Presbyterian Hospital, New York

72401

St. Bernards Medical Center, Jonesboro

85712

Tucson Medical Center, Tucson

91360

Los Robles Hospital & Medical Center, Thousand Oaks

92037

Scripps Health, La Jolla

95817

UC Davis Medical Center, Sacramento

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY